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Time-kill curves were plotted to determine reduction in log 10 CFU/mL over 48 hours. Bactericidal 83 activity (99.9% kill) was defined as a ≥ 3 log 10 CFU/mL reduction and bacteriostatic activity was 84 defined as a < 3 log 10 CFU/mL change in colony count from the initial inoculum.(20) The time to 85 kill 99.9% of the bacteria present was determined by non-linear regression (using a minimum of 86 4 data points) if r 2 ≥ 0.95 or by visual inspection. Enhancement of activity was defined as an 87 increase in kill of ≥ 2-log 10 CFU/mL by combination of antimicrobials versus the most active 88 single agent of that combination.(7) Improvement was defined as a 1 to 2-log 10 CFU/mL 89 increase in kill in comparison to the most active single agent, while combinations that resulted in 90 ≥ 1-log 10 bacterial growth in comparison to the most active single agent were considered to 91 represent antagonism. (7) The terms "improvement" and "enhancement" were used because our 92 simulations involve therapeutically obtained serum concentration and this does not permit the 93 mathematical modeling necessary to consider the standard terms "additivity" and "synergy" (7, 94 21). Indifference was defined as <1-log 10 CFU/mL change in activity. 95
96
Samples for pharmacokinetic analyses were obtained through the injection port at 0, 0.5, 1, 2, 4, 97 6, 8, and 24h for verification of target antibiotic concentrations. All samples were stored at 98 -80 o C until analysis. Daptomycin concentrations were determined by a previously described 99 and validated HPLC method (Center for Anti-Infective Research and Development, Hartford, 100 CT).(11) Vancomycin concentrations were determined by a homogeneous particle-enhanced 101 turbidmetric immunoassay (PETIA; Architect, Multigent®; Abbott Diagnostics Abbott Park, IL, 102 USA) at the Providence Veteran Affairs Medical Center.(11) The vancomycin assay has a 103 detection range of 0.5 to 80.0 µg/mL, and a between day sample precision and CV% of 1.6% 104 and < 5.0%, respectively. Linezolid concentrations were evaluated using HPLC (Infectious 105 Disease Pharmacokinetics Laboratory; Charles Peloquin) as previously described.(7) The half-106 life, AUC, Cmax, and minimum concentration (Cmin) of the antibiotics were determined by the 107 trapezoidal method utilizing PK Analyst software (Version 1.10, MicroMath Scientific Software, 108 Salt Lake City, UT). Maximum concentration (Cmax) to MIC ratios, the percent time above the 109 MIC (%T > MIC), and AUC antagonism at 24h for both isolates and 48h for one. Against L31, the activity of daptomycin 144 6mg/kg or 10mg/kg alone was significantly greater than daptomycin (either dose) plus linezolid 145 at 48h (mean difference in log CFU/mL 1.82-2.43, p<0.01). The differences in activity between 146 linezolid containing regimens (linezolid alone, linezolid plus vancomycin, daptomycin plus 147 linezolid) were not statistically significant at 48h for both isolates, but linezolid alone was less 148 active than either dose of daptomycin alone (mean differences 1.78-2.73, p<0.04). Adding 149 daptomycin 6mg/kg improved the activity of vancomycin at 48h (mean difference in log CFU/mL 150 1.65-2.20, p<0.03), but was not significantly different than daptomycin alone. In our study, regrowth was noted between 24 and 48h for both strains though no increases in 170 MIC were noted using Etests. This could be due to biofilm formation of these planktonic strains 171 after 24h, increasing growth without susceptibility changes, since biofilms can withstand 10-172 1000 times the concentrations of antibiotics compared to planktonic bacteria. According to 173 research by our group, approximately 50% of MRSA isolates from our institution form 174 biofilm.(29) Biofilm-forming isolates are known to cause persistent, difficult to treat infections 175 where combination therapy may be considered. The strains used in this study previously tested 176 positive for biofilm formation as noted above, using the same temperature and inoculum, with 177 similar media to this IVPD model. Over the 48h period tested, biofilm growth could seed 178 susceptible bacteria into the model during sampling, which would appear as regrowth. (9) A 179 previous study demonstrated a reduction in biofilm biomass, but no reduction in cell viability, 180 using combinations of linezolid and vancomycin against formed MRSA biofilms. (30) 181 182 Despite reaching the target of the estimated total AUC/MIC ratio for vancomycin of >400, and 183 with an estimated total vancomycin trough concentration of 15.5µg/mL, vancomycin did not 184 achieve bactericidal activity against L31 during the 48h period. This indicates that for an isolate 185 with a vancomycin MIC of 2mg/L, this regimen may not be adequate. 186
187
In regard to limitations, we evaluated two strains, and recognize that these observations may be 188 isolate-specific or dependent on the MICs of the isolates for each antibiotic. Improvement: 1-2 log 10 CFU/mL increase in kill over the most active component. 335 Enhancement: >2 log 10 CFU/mL increase in kill over the most active component. 336
Antagonism: ≥1 log 10 CFU/mL increase in growth over the most active component. 337
Indifference: <1 log 10 CFU/mL change in activity from the most active component. 
